Team
Neovacs employs 20 people, all of whom are based at its offices at 3/5 impasse Reille, Paris, 14th. 85% of the staff are dedicated to product and clinical development.
Management is made up of seven highly experienced and educated professionals. Neovacs’ scientists regularly publish in peer reviewed scientific journals and present their research at scientific meetings bringing together experts in the field.
The Board or Directors has 9 members, of whom 3 are independent. It oversees management with especial emphasis on strategic direction and objective-setting. Since May 28th 2003, the roles of Chairman and CEO have been separate.
